Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVRP.L Regulatory News (VRP)

  • There is currently no data for VRP

Total Voting Rights

31 Jul 2008 07:00

Verona Pharma plc (the "Company") Total Voting Rights

For the purposes of the transitional provisions of the Financial Services Authority's Disclosure and Transparency Rules, the total number of ordinary shares of 0.1p each in the capital of the Company in issue as at the date of this notice is 215,258,325 with each share carrying the right to one vote.

There are no shares held in treasury.

Therefore, the total number of voting rights in the Company is 215,258,325.

The above figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Disclosure and Transparency Rules.

For more information please contact:

Professor Clive Page, Chairman, Verona Pharma plc: 07971 504 931

David Youngman, WH Ireland Ltd: 0161 832 2174

vendor
Date   Source Headline
4th Oct 201312:06 pmPRNPlacing of shares
30th Sep 20137:00 amPRNHalf-yearly Report
23rd Sep 20137:00 amPRNNotice of Results
10th Sep 20137:00 amPRNClinical data presented at ERS
5th Sep 20137:01 amPRNPresentations at ERS
5th Sep 20137:00 amPRNAppointment of Richard Bungay as CFO
29th Jul 201310:13 amPRNGrant of Options
25th Jul 20131:23 pmPRNDirector Shareholding
24th Jul 20135:58 pmPRNHolding(s) in Company
23rd Jul 201312:45 pmPRNDirector Shareholding
24th Jun 20137:00 amPRNFirst patient dosed in clinical trial for VRP700
3rd Jun 20134:46 pmPRNResult of AGM
21st May 20134:00 pmPRNATS Tuesday Presentation
20th May 20137:00 amPRNATS Sunday Poster Presentations
16th May 20137:00 amPRNPresentations at ATS Conference
9th May 20138:05 amPRNPosting of Annual Report and AGM Notice
29th Apr 20137:00 amPRNNew Clinical and Scientific Advisory Board Announced
26th Apr 201310:17 amPRNDirector/PDMR Shareholding
15th Apr 20133:01 pmPRNGrant of Options
10th Apr 20133:07 pmPRNDirector's Dealing
10th Apr 201310:23 amPRNDirector Dealings
10th Apr 20137:00 amPRNFinal Results
19th Mar 20131:56 pmPRNHolding(s) in Company
5th Mar 20137:00 amPRNRPL554 demonstrates airway anti-inflammatory activity
28th Feb 20137:00 amPRNTotal Voting Rights
21st Feb 20132:35 pmPRNHolding(s) in Company
18th Feb 20132:53 pmPRNResult of General Meeting
31st Jan 201310:54 amPRNPlacing and Equity Finance Facility
24th Jan 20132:09 pmPRNNotice of Interest
18th Jan 201310:18 amPRNHolding(s) in Company
4th Jan 20132:59 pmPRNStatement Regarding Share Price Movement
12th Nov 201211:38 amPRNNotice of Interest
15th Oct 20122:01 pmPRNDirector Shareholding
12th Oct 20129:00 amPRNRPL554 Phase I/IIa data presented at ISAF 2012
26th Sep 20129:00 amPRNInvestor Presentation
17th Sep 201210:44 amPRNNew Option Scheme and Grant of Options
14th Sep 20127:00 amPRNHalf-yearly Report
6th Sep 20127:00 amPRNNotice of Interim Results
4th Sep 20127:30 amPRNVerona Pharma: RPL554 COPD Data Presented at ERS
3rd Sep 20129:30 amPRNNotice of Interest
28th Aug 20127:00 amPRNUS Patent Granted for Verona Pharma's RPL554
9th Jul 20127:00 amPRNVerona Pharma Investigates Anti-inflammatory - RPL554
1st Jun 20126:14 pmPRNResult of AGM
1st Jun 201211:30 amPRNCEO's Statement to Annual General Meeting
8th May 20124:56 pmPRNPosting of Annual Report
1st May 20127:00 amPRNVerona Pharma appoints new CEO
5th Apr 20127:00 amPRNVerona Pharma - Preliminary Unaudited Results
9th Mar 20127:00 amPRNVerona Pharma â€" First UK RPL554 anti-inflammatory trial
31st Jan 20127:00 amPRNTotal Voting Rights
16th Jan 201212:19 pmPRNNotification of Major Interest in Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.